Veru (VERU)
(Delayed Data from NSDQ)
$0.95 USD
0.00 (0.18%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.95 0.00 (0.21%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 39% (98 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.60 | 1.69 | 9.99 |
Current Quarter Estimate | -0.06 | 5.88 | 61.00 |
Year Ago Quarter Estimate | -0.13 | 4.88 | 54.84 |
Next Quarter Estimate | -0.06 | 7.06 | 63.00 |
Next Year Estimate | -0.29 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 75.89 | 11.80 | 15.67 |
Next Year | -7.41 | 26.00 | 9.31 |
Last 5 Years | -239.50 | 3.90 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 3.06 | 2.09 |
Price/Cash Flow (MRFY) | NA | 11.19 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -265.27% | 2.15% |
Return on Equity (TTM) | -130.13% | 13.47% |
Debt to Equity (MRQ) | NA | 17.49 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.